Relatedness of medically important strains of Saccharomyces cerevisiae as revealed by phylogenetics and metabolomics

Ten medically important Saccharomyces strains, comprising six clinical isolates of Saccharomyces cerevisiae and four probiotic strains of Saccharomyces boulardii, were characterized at the genetic and metabolic level and compared with non‐medical, commercial yeast strains used in baking and wine‐making. Strains were compared by genetic fingerprinting using amplified fragment length polymorphism (AFLP) analysis, by ribosomal DNA ITS1 sequencing and by metabolic footprinting using both direct injection mass spectrometry (DIMS) and gas chromatography–time of flight–mass spectrometry (GC–ToF–MS). Overall, the clinical isolates fell into different groupings when compared with the non‐medical strains, with good but not perfect correlation amongst strains at both the genetic and metabolic levels. Probiotic strains of S. boulardii that are used therapeutically to treat human gastro‐intestinal tract disorders showed tight clustering both genetically and metabolically. Metabolomics was found to be of value both as a taxonomic tool and as a means to investigate anomalous links between genotype and phenotype. Key discriminatory metabolites were identified when comparing the three main groups of clinical, probiotic and non‐medical strains and included molecules such as trehalose, myo‐inositol, lactic acid, fumaric acid and glycerol 3‐phosphate. This study confirmed the link between a subset of clinical isolates and baking or probiotic strains but also highlighted that in general the clinical strains were more diverse at both the genomic and metabolic levels. Copyright © 2008 John Wiley & Sons, Ltd.

[1]  Michael Edberg Hansen,et al.  A comparison of direct infusion MS and GC-MS for metabolic footprinting of yeast mutants. , 2007, Biotechnology and bioengineering.

[2]  D. Kell,et al.  Metabolic footprinting and systems biology: the medium is the message , 2005, Nature Reviews Microbiology.

[3]  Nancy G Love,et al.  Metabolic footprinting: a new approach to identify physiological changes in complex microbial communities upon exposure to toxic chemicals. , 2007, Environmental science & technology.

[4]  L. Di Francesco,et al.  In Vitro Activities of the New Antifungal Triazole SCH 56592 against Common and Emerging Yeast Pathogens , 2000, Antimicrobial Agents and Chemotherapy.

[5]  J. François,et al.  Acid trehalase in yeasts and filamentous fungi: localization, regulation and physiological function. , 2005, FEMS yeast research.

[6]  C. Gautier,et al.  Phylogenetic analysis of the Saccharomyces cerevisiae group based on polymorphisms of rDNA spacer sequences. , 1998, International journal of systematic bacteriology.

[7]  Markus J. Herrgård,et al.  Reconstruction and validation of Saccharomyces cerevisiae iND750, a fully compartmentalized genome-scale metabolic model. , 2004, Genome research.

[8]  Roderic D. M. Page,et al.  TreeView: an application to display phylogenetic trees on personal computers , 1996, Comput. Appl. Biosci..

[9]  Andrew Hayes,et al.  Comparative genomic hybridization provides new insights into the molecular taxonomy of the Saccharomyces sensu stricto complex. , 2004, Genome research.

[10]  Uwe Sauer,et al.  Metabolic-flux and network analysis in fourteen hemiascomycetous yeasts. , 2005, FEMS yeast research.

[11]  T. White.  Amplification and direct sequencing of fungal ribosomal RNA genes for phylogenetics , 1990 .

[12]  Joshua D. Knowles,et al.  Closed-loop, multiobjective optimization of analytical instrumentation: gas chromatography/time-of-flight mass spectrometry of the metabolomes of human serum and of yeast fermentations. , 2005, Analytical chemistry.

[13]  L. Jespersen,et al.  The taxonomic position of Saccharomyces boulardii as evaluated by sequence analysis of the D1/D2 domain of 26S rDNA, the ITS1-5.8S rDNA-ITS2 region and the mitochondrial cytochrome-c oxidase II gene. , 2003, Systematic and applied microbiology.

[14]  W. Kruskal,et al.  Use of Ranks in One-Criterion Variance Analysis , 1952 .

[15]  N. Shirley,et al.  Evidence for multiple interspecific hybridization in Saccharomyces sensu stricto species. , 2002, FEMS yeast research.

[16]  Patricia Muñoz,et al.  Saccharomyces cerevisiae fungemia: an emerging infectious disease. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  D. Wake,et al.  Phylogenetic reconstruction. , 1978, Science.

[18]  A. Vanlaere.  Trehalose, reserve and/or stress metabolite? , 1989 .

[19]  I. Castro,et al.  Molecular and physiological comparisons between Saccharomyces cerevisiae and Saccharomyces boulardii. , 2004, Canadian journal of microbiology.

[20]  Daniel Cozzolino,et al.  Metabolic profiling as a tool for revealing Saccharomyces interactions during wine fermentation. , 2006, FEMS yeast research.

[21]  L. Stateva,et al.  Genotypic and Physiological Characterization of Saccharomyces boulardii, the Probiotic Strain of Saccharomyces cerevisiae , 2007, Applied and Environmental Microbiology.

[22]  S. Villas-Bôas,et al.  Extracellular metabolomics: a metabolic footprinting approach to assess fiber degradation in complex media. , 2006, Analytical biochemistry.

[23]  W. Kruskal,et al.  Errata: Use of Ranks in One-Criterion Variance Analysis , 1953 .

[24]  J. Thomas LaMont,et al.  Saccharomyces boulardii Protease Inhibits the Effects of Clostridium difficile Toxins A and B in Human Colonic Mucosa , 1999, Infection and Immunity.

[25]  T. Boswell,et al.  Sensitivity of S. cerevisiae in haematology patients. , 2001, Journal of Hospital Infection.

[26]  A. Querol,et al.  Molecular characterization of clinical Saccharomyces cerevisiae isolates and their association with non-clinical strains. , 2004, Systematic and applied microbiology.

[27]  H. Helenius,et al.  Fungal colonization of haematological patients receiving cytotoxic chemotherapy: emergence of azole-resistant Saccharomyces cerevisiae. , 2000, The Journal of hospital infection.

[28]  G. Fadda,et al.  Molecular tools for differentiating probiotic and clinical strains of Saccharomyces cerevisiae. , 2005, International journal of food microbiology.

[29]  N. Goto-Yamamoto,et al.  AFLP analysis of type strains and laboratory and industrial strains of Saccharomyces sensu stricto and its application to phenetic clustering , 2001, Yeast.

[30]  D. Metzgar,et al.  Fatal Saccharomyces cerevisiae Aortic Graft Infection , 2002, Journal of Clinical Microbiology.

[31]  P. Mahalanobis.  On the generalized distance in statistics , 1936 .

[32]  D. Kell,et al.  High-throughput classification of yeast mutants for functional genomics using metabolic footprinting , 2003, Nature Biotechnology.

[33]  P. Savelkoul,et al.  Use of Amplified Fragment Length Polymorphism Analysis To Identify Medically Important Candida spp., Including C. dubliniensis , 2003, Journal of Clinical Microbiology.

[34]  B. Palsson,et al.  Genome-scale reconstruction of the Saccharomyces cerevisiae metabolic network. , 2003, Genome research.

[35]  A. Querol,et al.  Food and probiotic strains from the Saccharomyces cerevisiae species as a possible origin of human systemic infections. , 2006, International journal of food microbiology.

[36]  A. Querol,et al.  A comparison of clinical and food Saccharomyces cerevisiae isolates on the basis of potential virulence factors , 2006, Antonie van Leeuwenhoek.

[37]  G. Fink,et al.  A Saccharomyces gene family involved in invasive growth, cell-cell adhesion, and mating. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[38]  N. Saitou,et al.  The neighbor-joining method: a new method for reconstructing phylogenetic trees. , 1987, Molecular biology and evolution.

[39]  Gianni Cesareni,et al.  Role of 14-3-3 proteins in the regulation of neutral trehalase in the yeast Saccharomyces cerevisiae. , 2008, FEMS yeast research.

[40]  C. Pothoulakis,et al.  Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-kappaB-mediated IL-8 gene expression. , 2006, Biochemical and biophysical research communications.

[41]  S. Henry,et al.  The emergence of yeast lipidomics. , 2007, Biochimica et biophysica acta.

[42]  F. Barchiesi,et al.  In vitro activity of five antifungal agents against clinical isolates of Saccharomyces cerevisiae. , 1998, Medical mycology.

[43]  P. Mendes,et al.  The origin of correlations in metabolomics data , 2005, Metabolomics.

[44]  K. Verbeke,et al.  Molecular Monitoring of the Fecal Microbiota of Healthy Human Subjects during Administration of Lactulose and Saccharomyces boulardii , 2006, Applied and Environmental Microbiology.

[45]  Royston Goodacre,et al.  Metabolic footprinting as a tool for discriminating between brewing yeasts , 2007, Yeast.

[46]  P. Fernandes.  How does yeast respond to pressure? , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[47]  M. Collins,et al.  Use of an rRNA internal transcribed spacer region to distinguish phylogenetically closely related species of the genera Zygosaccharomyces and Torulaspora. , 1996, International journal of systematic bacteriology.

[48]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[49]  N. Russell,et al.  Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients. , 2002, The Journal of hospital infection.

[50]  Johanna Smeyers-Verbeke,et al.  Chapter 33 - Supervised Pattern Recognition , 1998 .

[51]  Douglas B. Kell,et al.  Discrimination of Modes of Action of Antifungal Substances by Use of Metabolic Footprinting , 2004, Applied and Environmental Microbiology.

[52]  Douglas B. Kell,et al.  Statistical strategies for avoiding false discoveries in metabolomics and related experiments , 2007, Metabolomics.

[53]  L. Mcfarland.  Saccharomyces boulardii is not Saccharomyces cerevisiae. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[54]  I. Longden,et al.  EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.

[55]  SELECTIVE RESTRICTION FRAGMENT AMPLIFICATION: A GENERAL METHOD FOR DNA FINGERPRINTING , 2008 .

[56]  G. Liti,et al.  Inferences of evolutionary relationships from a population survey of LTR‐retrotransposons and telomeric‐associated sequences in the Saccharomyces sensu stricto complex , 2005, Yeast.